Are_VBP Three_NP Sputum_NP Acid-Fast_NP Bacillus_NN Smears_NP Necessary_NP for_IN Discontinuing_NP Tuberculosis_NN Isolation_NN ?_SENT To_TO evaluate_VB the_DT efficacy_NN of_IN three_CD sputum_NN acid-fast_JJ bacillus_NN (_( AFB_NP )_) smears_VBZ to_TO rule_VB out_RP pulmonary_JJ tuberculosis_NN ,_, sputum_NN AFB_NP smear_NN and_CC culture_NN results_NNS were_VBD analyzed_VBN at_IN two_CD university-affiliated_JJ teaching_NN hospitals_NNS ._SENT The_DT negative_JJ predictive_JJ value_NN of_IN the_DT smear_NN increased_VBN by_IN only_RB 0.2_CD %_NN on_IN days_NNS 2_CD and_CC 3_CD each_DT ,_, indicating_VBG that_IN in_IN low-prevalence_NN populations_NNS ,_, there_EX is_VBZ limited_JJ value_NN in_IN requiring_VBG three_CD negative_JJ sputum_NN AFB_NN smears_NNS before_IN discontinuing_VBG tuberculosis_NN isolation_NN ._SENT Current_JJ guidelines_NNS recommend_VBP that_IN patients_NNS suspected_VBN of_IN having_VBG active_JJ pulmonary_JJ tuberculosis_NN (_( TB_NN )_) in_IN a_DT health_NN care_NN facility_NN should_MD be_VB placed_VBN in_IN a_DT TB_NN isolation_NN room_NN ._SENT These_DT recommendations_NNS state_VBP that_IN isolation_NN can_MD be_VB discontinued_VBN when_WRB the_DT diagnosis_NN of_IN TB_NN is_VBZ ruled_VBN out_IN or_CC when_WRB a_DT determination_NN has_VBZ been_VBN made_VBN that_IN the_DT patient_NN is_VBZ noninfectious_JJ ._SENT Once_RB a_DT patient_NN has_VBZ been_VBN diagnosed_VBN with_IN TB_NN ,_, "_`` isolation_NN should_MD be_VB discontinued_VBN only_RB when_WRB the_DT patient_NN is_VBZ on_IN effective_JJ therapy_NN ,_, is_VBZ improving_VBG clinically_RB ,_, and_CC has_VBZ had_VBN 3_CD consecutive_JJ negative_JJ sputum_NN acid_NN fast_JJ bacillus_NN (_( AFB_NP )_) smear_NN examinations_NNS collected_VBN on_IN different_JJ days_NNS "_'' ._SENT In_IN clinical_JJ practice_NN ,_, patients_NNS suspected_VBN of_IN having_VBG pulmonary_JJ TB_NN are_VBP placed_VBN routinely_RB in_IN TB_NN isolation_NN ._SENT Although_IN most_JJS United_NP States_NP hospitals_NNS require_VBP three_CD sputum_NN AFB_NP smears_VBZ to_TO discontinue_VB isolation_NN ,_, the_DT published_VBN literature_NN reveals_VBZ limited_JJ data_NNS to_TO support_VB this_DT 3-day_JJ requirement_NN (_( ,_, -_: ,_, )_) ._SENT Therefore_RB ,_, we_PP examined_VBD the_DT value_NN of_IN this_DT practice_NN at_IN two_CD New_NP Jersey_NP university-affiliated_JJ teaching_NN hospitals_NNS ._SENT (_( This_DT work_NN was_VBD presented_VBN in_IN part_NN at_IN the_DT 39th_JJ Interscience_NN Conference_NN on_IN Antimicrobial_JJ Agents_NNS and_CC Chemotherapy_NN ,_, San_NP Francisco_NP ,_, Calif._NP ,_, 26_CD to_TO 29_CD September_NP 1999_CD [_SYM P._NP Mathew_NP ,_, B._NP Vazirani_NP ,_, Y._NP H._NP Kuo_NP ,_, R._NP H._NP K._NP Eng_NP ,_, S._NP M._NP Smith_NP ,_, and_CC M._NP P._NP Weinstein_NP ,_, Abstr_NP ._SENT 39th_JJ Intersci_NP ._SENT Conf_NP ._SENT Antimicrob_NN ._SENT Agents_NPS Chemother_NP ._SENT ,_, abstr_NN ._SENT 850_CD ,_, 1999_CD ]_SYM ._SENT )_) Mycobacteriology_NN laboratory_NN records_NNS for_IN all_DT sputum_NN AFB_NN smear_NN and_CC culture_NN tests_NNS performed_VBN at_IN Robert_NP Wood_NP Johnson_NP University_NP Hospital_NP ,_, New_NP Brunswick_NP ,_, N.J._NP ,_, and_CC the_DT Veterans_NPS Affairs_NPS Medical_NP Center_NP ,_, East_NP Orange_NP ,_, N.J._NP ,_, were_VBD reviewed_VBN from_IN September_NP 1993_CD through_IN September_NP 1998_CD ._SENT Specimens_NNS from_IN patients_NNS who_WP had_VBD three_CD separate_JJ sputum_NN collections_NNS (_( induced_VBN or_CC expectorated_VBN )_) submitted_VBN for_IN AFB_NP smear_NN and_CC culture_NN on_IN different_JJ days_NNS within_IN a_DT 14-day_JJ period_NN were_VBD included_VBN in_IN the_DT analysis_NN ._SENT Specimens_NNS were_VBD not_RB included_VBN in_IN the_DT analysis_NN if_IN they_PP were_VBD repeat_NN sputum_NN series_NN from_IN a_DT patient_NN already_RB included_VBD in_IN the_DT study_NN ._SENT Patients_NNS who_WP contributed_VBD fewer_JJR than_IN three_CD sputum_NN AFB_NN specimens_NNS within_IN a_DT 14-day_JJ period_NN were_VBD also_RB excluded_VBN ._SENT Sputum_NN smears_NNS were_VBD decontaminated_VBN ,_, digested_VBN ,_, and_CC concentrated_VBN by_IN standard_JJ laboratory_NN methods_NNS ._SENT Smears_NNS were_VBD screened_VBN by_IN using_VBG auramine_JJ O_NN stain_NN followed_VBN by_IN Kinyoun_NP stain_NN confirmation_NN ._SENT Sputum_NN sediments_NNS were_VBD inoculated_VBN to_TO BACTEC_NP 12B_NP broth_NN (_( Becton_NP Dickinson_NP Microbiology_NP Systems_NP ,_, Sparks_NP ,_, Md._NP )_) and_CC nonselective_JJ and_CC selective_JJ Middlebrook_NP 7H11_JJ solid_JJ media_NNS ._SENT Cultures_NNS were_VBD incubated_VBN at_IN 37C_JJ in_IN a_DT 5_CD %_NN CO2_JJ incubator_NN for_IN up_IN to_TO 6_CD weeks_NNS ._SENT Positive_JJ cultures_NNS were_VBD identified_VBN with_IN the_DT AccuProbe_NP DNA_NP hybridization_NN assay_NN (_( GenProbe_NP ,_, San_NP Diego_NP ,_, Calif._NP )_) ._SENT If_IN more_JJR than_IN one_CD specimen_NN was_VBD received_VBN on_IN a_DT given_VBN day_NN ,_, either_CC they_PP were_VBD pooled_VBN or_CC only_RB the_DT first_JJ specimen_NN was_VBD included_VBN in_IN the_DT data_NNS analysis_NN ._SENT The_DT sensitivity_NN ,_, specificity_NN ,_, and_CC negative_JJ predictive_JJ values_NNS (_( NPVs_NP )_) of_IN the_DT sputum_NN smear_NN examination_NN were_VBD calculated_VBN by_IN using_VBG the_DT sputum_NN culture_NN results_NNS as_IN the_DT "_`` gold_JJ standard_NN ._SENT "_`` Confidence_NN intervals_NNS (_( CI_NP )_) were_VBD calculated_VBN by_IN the_DT exact_JJ method_NN ._SENT For_IN the_DT difference_NN between_IN proportions_NNS ,_, the_DT estimations_NNS of_IN confidence_NN interval_NN were_VBD based_VBN on_IN the_DT normal_JJ approximation_NN ._SENT During_IN the_DT study_NN period_NN ,_, 5,336_CD sputum_NN specimens_NNS were_VBD submitted_VBN for_IN AFB_NP smear_NN and_CC culture_NN from_IN 1,981_CD patients_NNS ._SENT M._NP tuberculosis_NN grew_VBD in_IN 78_CD specimens_NNS from_IN 25_CD patients_NNS at_IN Robert_NP Wood_NP Johnson_NP University_NP Hospital_NP and_CC 125_CD specimens_NNS from_IN 31_CD patients_NNS at_IN Veterans_NPS Affairs_NPS Medical_NP Center_NP ,_, a_DT total_NN of_IN 203_CD positive_JJ cultures_NNS from_IN 56_CD patients_NNS ._SENT The_DT overall_JJ prevalence_NN of_IN culture-positive_JJ M._NP tuberculosis_NN in_IN sputum_NN specimens_NNS was_VBD 2.83_CD %_NN ._SENT Sputum_NN AFB_NN smears_NNS and_CC culture_NN results_NNS for_IN M._NP tuberculosis_NN are_VBP shown_VBN in_IN Table_NP ._SENT Sputum_NN AFB_NP smears_NNS had_VBD a_DT sensitivity_NN of_IN 67.5_CD %_NN (_( 95_CD %_NN CI_NP ,_, 60.6_CD to_TO 73.9_CD )_) and_CC specificity_NN of_IN 97.5_CD %_NN (_( 95_CD %_NN CI_NP ,_, 97.0_CD to_TO 97.9_CD )_) when_WRB the_DT data_NNS from_IN the_DT two_CD hospitals_NNS were_VBD combined_VBN ._SENT TABLE_NN 1_CD |_SYM Sputum_NP AFB_NP smear_NN and_CC culture_NN results_NNS for_IN M._NP tuberculosis_NN Only_RB 488_CD patients_NNS (_( 24.6_CD %_NN )_) produced_VBD three_CD separate_JJ sputum_NN specimens_NNS on_IN different_JJ days_NNS during_IN a_DT 14-day_JJ period_NN ._SENT Of_IN these_DT ,_, 27_CD patients_NNS had_VBD positive_JJ cultures_NNS ._SENT The_DT results_NNS of_IN AFB_NP smear_NN and_CC culture_NN categorized_VBN by_IN the_DT sequence_NN in_IN which_WDT specimens_NNS were_VBD submitted_VBN are_VBP shown_VBN in_IN Table_NP ._SENT Eight_CD of_IN 27_CD (_( 29.6_CD %_NN )_) patients_NNS were_VBD AFB_NP smear_NN negative_NN but_CC culture_NN positive_JJ for_IN M._NP tuberculosis_NN ._SENT Of_IN 19_CD smear-positive_JJ patients_NNS ,_, 17_CD (_( 89.5_CD %_NN )_) were_VBD identified_VBN as_IN positive_JJ on_IN the_DT first_JJ smear_NN ,_, 1_CD (_( 5.3_CD %_NN )_) was_VBD identified_VBN on_IN the_DT second_JJ smear_NN ,_, and_CC 1_CD (_( 5.3_CD %_NN )_) was_VBD identified_VBN on_IN the_DT third_JJ smear_NN ._SENT TABLE_NN 2_CD |_SYM Results_NNS of_IN AFB_NP smear_NN and_CC culture_NN categorized_VBN by_IN the_DT sequence_NN in_IN which_WDT specimens_NNS were_VBD submitted_VBN The_DT NPV_NP of_IN AFB_NP smears_NNS according_VBG to_TO the_DT day_NN of_IN the_DT first_JJ positive_JJ smear_NN is_VBZ shown_VBN in_IN Table_NP ._SENT As_RB is_VBZ evident_JJ ,_, the_DT incremental_JJ value_NN of_IN second_JJ and_CC third_JJ specimens_NNS after_IN a_DT first_JJ negative_JJ smear_NN was_VBD negligible_JJ ._SENT TABLE_NN 3_CD |_SYM NPV_NP of_IN AFB_NP smears_NNS according_VBG to_TO the_DT day_NN of_IN collection_NN In_IN this_DT study_NN the_DT overwhelming_JJ majority_NN of_IN patients_NNS whose_WP$ AFB_NP smears_NNS were_VBD negative_JJ and_CC for_IN whom_WP TB_NN isolation_NN was_VBD discontinued_VBN were_VBD identified_VBN with_IN the_DT first_JJ sputum_NN AFB_NP smear_NN ._SENT The_DT incremental_JJ benefits_NNS of_IN 0.2_CD %_NN with_IN the_DT second_JJ specimen_NN and_CC of_IN 0.2_CD %_NN with_IN the_DT third_JJ specimen_NN have_VBP to_TO be_VB weighed_VBN against_IN the_DT costs_NNS of_IN additional_JJ patient_JJ days_NNS in_IN TB_NN isolation_NN ._SENT Current_JJ recommendations_NNS were_VBD formulated_VBN at_IN a_DT time_NN when_WRB there_EX was_VBD resurgence_NN in_IN TB_NN ._SENT However_RB ,_, there_EX is_VBZ a_DT paucity_NN of_IN published_VBN literature_NN directly_RB supporting_VBG the_DT current_JJ clinical_JJ practice_NN of_IN continued_JJ TB_NN isolation_NN until_IN three_CD sputum_NN smears_NNS are_VBP negative_JJ ._SENT The_DT 1985_CD U.S._NP Public_NP Service_NP Guide_NP for_IN level_JJ III_NP laboratories_NNS suggested_VBD that_IN the_DT number_NN of_IN specimens_NNS submitted_VBN for_IN culture_NN be_VB determined_VBN by_IN the_DT results_NNS of_IN early_JJ smear_NN examination_NN ,_, and_CC Bates_NP stated_VBD that_IN three_CD specimens_NNS were_VBD sufficient_JJ when_WRB at_IN least_JJS two_CD of_IN the_DT first_JJ three_CD smears_NNS were_VBD positive_JJ ._SENT Data_NNS to_TO support_VB the_DT numbers_NNS of_IN smears_NNS recommended_VBN to_TO diagnose_VB pulmonary_JJ TB_NN were_VBD derived_VBN from_IN field_NN studies_NNS in_IN high-prevalence_NN areas_NNS in_IN South_NP East_NP Asia_NP or_CC from_IN preselected_JJ symptomatic_JJ patients_NNS with_IN prolonged_JJ cough_NN ,_, purulent_JJ sputum_NN ,_, and_CC hemoptysis_NN ._SENT In_IN these_DT populations_NNS ,_, two_CD consecutive_JJ smears_NNS were_VBD sufficient_JJ for_IN detecting_VBG TB_NN ._SENT In_IN a_DT study_NN conducted_VBN at_IN the_DT Tuberculosis_NN Chemotherapy_NN Centre_NP ,_, Madras_NP ,_, India_NP ,_, in_IN the_DT 1950s_NNS ,_, two_CD immediate_JJ (_( spot_NN )_) collections_NNS were_VBD compared_VBN with_IN two_CD specimens_NNS collected_VBN overnight_RB in_IN 348_CD sputum-positive_JJ patients_NNS ,_, the_DT great_JJ majority_NN of_IN whom_WP had_VBD extensive_JJ disease_NN ._SENT For_IN AFB_NP smears_NNS ,_, the_DT percentages_NNS reported_VBD positive_NN were_VBD 66.2_CD and_CC 76.4_CD %_NN for_IN the_DT spot_NN and_CC collection_NN methods_NNS ,_, respectively_RB ,_, and_CC 89.7_CD and_CC 93.7_CD %_NN for_IN culture_NN ._SENT Limitations_NNS in_IN the_DT data_NNS presented_VBD make_VB calculation_NN of_IN sensitivity_NN and_CC specificities_NNS impossible_JJ ._SENT In_IN retrospective_JJ studies_NNS by_IN MacGregor_NP and_CC Greenbaum_NP et_FW al._FW ,_, it_PP was_VBD concluded_VBN that_IN no_DT more_JJR than_IN three_CD sputum_NN specimens_NNS were_VBD necessary_JJ for_IN the_DT diagnosis_NN of_IN TB_NN if_IN ,_, in_IN fact_NN ,_, the_DT diagnosis_NN was_VBD to_TO be_VB made_VBN by_IN sputum_NN examination_NN ._SENT The_DT same_JJ criteria_NNS were_VBD recommended_VBN for_IN discontinuing_VBG isolation_NN ._SENT However_RB ,_, neither_DT study_NN specifically_RB provided_VBD data_NNS with_IN regard_NN to_TO the_DT number_NN of_IN smears_NNS ._SENT These_DT data_NNS have_VBP helped_VBN form_VB the_DT basis_NN of_IN the_DT current_JJ three-specimen_NN requirement_NN for_IN ruling_VBG out_RP pulmonary_JJ TB_NN ._SENT The_DT probable_JJ rationale_NN behind_IN this_DT recommendation_NN is_VBZ that_IN some_DT patients_NNS shed_VBD mycobacteria_NNS irregularly_RB and_CC in_IN small_JJ numbers_NNS and_CC ,_, thus_RB ,_, increasing_VBG the_DT number_NN of_IN specimens_NNS would_MD increase_VB the_DT yield_NN ._SENT With_IN regard_NN to_TO the_DT recommendation_NN for_IN early_JJ morning_NN specimens_NNS ,_, the_DT assumption_NN is_VBZ that_IN M._NP tuberculosis_NN would_MD be_VB present_JJ in_IN maximum_JJ concentration_NN in_IN sputum_NN after_IN pooling_VBG overnight_JJ in_IN the_DT respiratory_JJ tract_NN ._SENT Two_CD recently_RB published_VBN reports_NNS have_VBP provided_VBN results_NNS similar_JJ to_TO the_DT observations_NNS in_IN the_DT present_JJ study_NN ._SENT Nelson_NP et_FW al._FW ,_, in_IN a_DT 10-year_JJ retrospective_JJ study_NN in_IN Minneapolis_NP ,_, Minn._NP ,_, found_VBD that_IN the_DT majority_NN of_IN culture-proven_JJ pulmonary_JJ TB_NN cases_NNS were_VBD diagnosed_VBN from_IN the_DT first_JJ or_CC second_JJ sputum_NN specimens_NNS and_CC that_IN only_RB rarely_RB was_VBD the_DT third_JJ specimen_NN of_IN diagnostic_JJ value_NN ._SENT Craft_NP et_FW al._FW reviewed_VBN 4_CD years_NNS '_POS worth_NN of_IN data_NNS at_IN the_DT University_NP of_IN North_NP Carolina_NP and_CC concluded_VBD that_IN "_`` modifying_VBG the_DT smear_NN policy_NN from_IN three_CD to_TO two_CD negative_JJ smears_NNS would_MD have_VB resulted_VBN in_IN no_DT increased_VBN risk_NN of_IN spreading_VBG TB_NN and_CC would_MD decrease_VB the_DT number_NN of_IN days_NNS patients_NNS are_VBP unnecessarily_RB placed_VBN under_IN airborne_JJ precautions_NNS "_'' in_IN their_PP$ institution_NN ._SENT Our_PP$ study_NN and_CC those_DT cited_VBD above_RB raise_VB the_DT question_NN of_IN whether_IN three_CD sputum_NN AFB_NN smears_NNS are_VBP necessary_JJ before_IN discontinuing_VBG TB_NN isolation_NN ._SENT In_IN the_DT two_CD hospitals_NNS that_IN we_PP studied_VBD ,_, it_PP took_VBD up_RP to_TO 14_CD days_NNS to_TO obtain_VB a_DT third_JJ sputum_NN specimen_NN for_IN 488_CD of_IN 1,981_CD patients_NNS ,_, further_RBR pointing_VBG to_TO the_DT impracticality_NN of_IN the_DT recommendations_NNS in_IN routine_JJ clinical_JJ practice_NN ._SENT Whether_IN multiple_JJ negative_JJ sputum_NN AFB_NN smears_NNS obtained_VBN during_IN a_DT shorter_JJR period_NN such_JJ as_IN 24_CD h_NN would_MD obviate_VB the_DT collections_NNS on_IN subsequent_JJ days_NNS has_VBZ not_RB been_VBN studied_VBN ._SENT Since_IN the_DT incidence_NN of_IN TB_NN is_VBZ once_RB again_RB declining_VBG in_IN the_DT United_NP States_NPS ,_, a_DT reassessment_NN of_IN the_DT requirement_NN for_IN three_CD negative_JJ sputum_NN smears_NNS to_TO discontinue_VB TB_NN isolation_NN seems_VBZ warranted_VBN ._SENT However_RB ,_, once_RB the_DT initial_JJ AFB_NP smear_NN ,_, or_CC arguably_RB two_CD smears_NNS ,_, is_VBZ negative_JJ ,_, the_DT additional_JJ specimens_NNS for_IN culture_NN can_MD be_VB obtained_VBN after_IN isolation_NN is_VBZ discontinued_VBN ._SENT Exceptions_NNS to_TO this_DT recommendation_NN may_MD be_VB necessary_JJ when_WRB the_DT pretest_JJ probability_NN of_IN TB_NN is_VBZ high_JJ ._SENT 